Journal
PHARMACEUTICAL RESEARCH
Volume 26, Issue 3, Pages 674-682Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-008-9786-x
Keywords
fluorescence; Gd-DTPA; magnetic resonance imaging (MRI); photoacoustic ultrasound (PAUS) imaging; silver
Funding
- American Heart Association
- National Science Foundation Integrative Graduate Education and Research
- Division Of Chemistry
- Direct For Mathematical & Physical Scien [0821312] Funding Source: National Science Foundation
Ask authors/readers for more resources
With the broadening field of nanomedicine poised for future molecular level therapeutics, nano- and microparticles intended for the augmentation of either single- or multimodal imaging are created with PLGA as the chief constituent and carrier. Emulsion techniques were used to encapsulate hydrophilic and hydrophobic imaging contrast agents in PLGA particles. The imaging contrast properties of these PLGA particles were further enhanced by reducing silver onto the PLGA surface, creating a silver cage around the polymeric core. The MRI contrast agent Gd-DTPA and the exogenous dye rhodamine 6G were both encapsulated in PLGA and shown to enhance MR and fluorescence contrast, respectively. The silver nanocage built around PLGA nanoparticles exhibited strong near infrared light absorbance properties, making it a suitable contrast agent for optical imaging strategies such as photoacoustic imaging. The biodegradable polymer PLGA is an extremely versatile nano- and micro-carrier for several imaging contrast agents with the possibility of targeting diseased states at a molecular level.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available